Happy Mammoth Hormone Harmony Review: The Claims a Regulator Told Them to Drop

Affiliate disclosure: HerWellReport is reader-supported. If you buy through a link on this page we may earn a commission, at no extra cost to you. This is not medical advice. We have not used or tested this product; see our full disclosure.

Happy Mammoth’s Hormone Harmony is one of the most heavily marketed menopause supplements in the US, built on podcast ads, Instagram testimonials and a claim of “2.4 million women worldwide.” It is also the rare product in this category that a formal advertising watchdog has actually investigated — and in August 2024, that watchdog told the company to stop making four of its central menopause claims. Almost nothing written about Hormone Harmony online mentions that decision. This review covers what is actually disclosed about the formula, what the regulator found, and what is left once the unsupported claims are set aside.

The quick answer

Hormone Harmony is a 12-ingredient capsule blend sold at $69.99 for a single jar, with no individual doses published for any ingredient. In August 2024, the National Advertising Division (NAD) of BBB National Programs — the advertising industry’s own self-regulatory body — reviewed the product’s marketing and recommended Happy Mammoth discontinue four specific claims: that it “relieves symptoms of menopause,” “relieves hot flashes,” “improves sleep quality,” and “reduces bloating and gas.” NAD’s stated reason was that there had been no testing on the finished product itself, and the ingredient studies Happy Mammoth submitted had limitations that couldn’t support even a qualified version of those claims. Happy Mammoth agreed to comply. Separately, the nonprofit watchdog TruthInAdvertising.org (TINA.org) has published its own critique of the same marketing. Nothing here means the ingredients are worthless — several have real, if limited, research behind them — but the specific promises that sell this product are the ones a regulator already asked the company to stop making. (Short on time? Skip to our alternative.)

What’s actually in it — and what isn’t disclosed

The label lists 12 plant extracts plus vitamin B6: maca root, broccoli sprout, chaste tree berry, ashwagandha root (KSM-66), wild yam, fennel seed, berberine, gymnema, rosemary, chamomile, and rhodiola rosea, alongside capsule fillers.¹ That is a broad list drawing from menopause, PMS, blood-sugar and stress-support traditions all at once. What the label does not include, anywhere on the product page, is a single milligram amount for any of the twelve — no supplement facts panel breaking out individual doses, only the ingredient names.¹ That matters for the same reason it matters on FemiCore’s own label: without a published dose, nobody outside the company can check whether an ingredient is present at a level that matches the research behind it, or at a token amount that exists mainly for the label copy.

The serving directions are three capsules once daily, 72 capsules per jar¹ — which works out to a 24-day supply per jar, not a full calendar month. Anyone budgeting a monthly cost from the advertised per-jar price should use 24 days, not 30, or the real cost per month runs higher than it first appears.

Price and guarantee

A single jar is $69.99 at full price. Subscribing drops the per-jar cost to $59.49 for one jar, $50.99 per jar when buying two, and $44.62 per jar when buying four — all recurring, auto-shipped orders rather than one-time purchases.¹ Happy Mammoth advertises a 60-day money-back guarantee, stated on the product page as applying to single-jar purchases.¹ This is a direct-to-consumer brand selling through its own Shopify store, not a ClickBank-processed offer — so unlike FemiCore or MenoRescue, there is no separate processor refund window layered underneath the seller’s promise; the 60 days is the whole guarantee, administered by Happy Mammoth itself through its own refund policy.

What the National Advertising Division actually found

NAD reviews advertising claims through a routine monitoring program — this case wasn’t triggered by a competitor complaint, but by NAD examining Hormone Harmony’s marketing on its own initiative.³ NAD is part of BBB National Programs, an independent, industry-funded body that reviews advertising claims across the US; it has no government enforcement power of its own, but a company that refuses to comply with its recommendations can be referred to the Federal Trade Commission.³

NAD’s recommendation, published August 20, 2024, was that Happy Mammoth discontinue four specific claims: “Relieves symptoms of Menopause,” “Relieves hot flashes,” “Improve sleep quality,” and “Reduces bloating and gas.” The stated basis was that Happy Mammoth had not conducted testing on the finished Hormone Harmony product itself, and the ingredient-level studies it submitted in support had limitations that made them inadequate — not just for the original unqualified claims, but for any more carefully worded version of them either.²

NAD’s decision wasn’t a blanket rejection of the formula. It said Happy Mammoth could continue describing fennel’s and chaste tree berry’s effects on menopausal symptoms where that description is supported by research, and could describe ashwagandha’s and chamomile’s traditional or historical uses — provided those statements are clearly qualified so they don’t imply proven efficacy.² That is a meaningfully narrower set of claims than “relieves hot flashes,” and it is the distinction most marketing for this product does not make.

Happy Mammoth’s own statement, issued alongside the decision, said the company “agrees to comply with NAD’s recommendations but is disappointed with some of NAD’s critiques.”³ Whether the marketing you actually see today reflects that compliance is worth checking for yourself — self-regulatory recommendations govern future advertising, and enforcement relies on NAD’s own follow-up monitoring rather than a permanent injunction.

A second watchdog raised a related, sharper concern

TINA.org, a nonprofit consumer-protection group that monitors supplement advertising, published its own article on Hormone Harmony flagging that the product is marketed at roughly $70 a month with claims of eliminating hot flashes, anxiety, depression and memory problems — claims TINA.org argues would legally require FDA review as drug claims if made about eliminating a specific diagnosed condition, something no dietary supplement undergoes.⁴ TINA.org also noted the tension between the page’s own FDA disclaimer (“statements… have not been evaluated by the FDA”) and marketing language it says reads as if the product were an approved treatment.⁴ In October 2024, TINA.org sent compliance letters to 100 menopause supplement marketers, Happy Mammoth included, and pointed to NIH and North American Menopause Society experts who have found this category of supplement ineffective for menopause symptoms in controlled research.⁴ That last point echoes what we’ve reported on our own menopause-supplement coverage: the 2023 NAMS position statement places most non-hormonal botanical supplements, soy isoflavones among them, in the “not recommended or insufficient evidence” category — see our evidence-ranked hot flush guide for the full breakdown.

What’s genuinely worth knowing about the ingredients

Setting the regulatory story aside, a few of the twelve ingredients do have real research behind them for other uses, even without published doses to check them against here. Ashwagandha (KSM-66) has manufacturer-linked menopause trials showing symptom-score improvements, though a closer look at the strongest of them finds the cortisol reduction it measures doesn’t track with women’s actual reported stress relief — we cover that gap, and KSM-66’s real safety profile, in our standalone ashwagandha review. Chaste tree berry has a reasonable trial record for PMS but a much thinner one for menopause specifically, and it can reduce the effectiveness of hormone therapy and birth control. Berberine, present here without a stated dose, carries real interactions with diabetes medications, statins and blood thinners that matter regardless of how much of it a capsule contains — if you take any of those, that is worth raising with a pharmacist before adding this product, not something to assume away because the ingredient is a plant extract.

Bottom line

Hormone Harmony is not a scam in the sense of an empty bottle or a company that disappears with your money — it is a real, actively sold product from an established DTC brand with a stated refund policy. But it is also the one product in this cluster where an independent advertising regulator has already looked at the marketing and found the central claims unsupported by any testing on the actual product. No dose disclosure means there’s no way to check any of the twelve ingredients against the research behind them, and the price works out to roughly $70 for 24 days rather than a full month. If you’re comparing menopause options, that combination — undisclosed doses plus a regulator-documented claims problem — is a lot to accept on faith for $70.

Frequently asked questions

Did a regulator actually investigate Happy Mammoth Hormone Harmony?
Yes. In August 2024, the National Advertising Division (NAD) of BBB National Programs, the advertising industry’s self-regulatory body, recommended Happy Mammoth discontinue four claims — that the product relieves menopause symptoms, relieves hot flashes, improves sleep quality, and reduces bloating and gas — citing a lack of testing on the finished product. Happy Mammoth agreed to comply.

Does Hormone Harmony publish the doses of its ingredients?
No. The product page lists 12 plant extracts plus vitamin B6 by name only, with no supplement facts panel showing individual milligram amounts for any ingredient.

How long does one jar actually last?
72 capsules at the labeled serving of three capsules a day works out to a 24-day supply, not a full calendar month.

What is the refund policy?
Happy Mammoth advertises a 60-day money-back guarantee on single-jar purchases through its own refund policy. This is a direct manufacturer guarantee, not a ClickBank-processed offer, so there is no separate processor refund window layered underneath it.

More from HerWellReport

• MenoRescue Review: What’s In It, What the Evidence Says, and Who It’s For
• Best Menopause Supplements: What Is Actually In Them
• Hot Flushes: What Actually Works, Ranked by Evidence
• Ashwagandha for Menopause: What the Evidence Actually Shows
• One A Day Women’s Menopause Formula: An Honest Ingredient Review
• O Positiv MENO Review: The Capsule and the Gummy Aren’t the Same Dose